MeMed, a leader in host-response technology, today announced that Health Canada has granted Medical Device License (MDL) for MeMed BV(R) on the MeMed Key(R) platform. This approval introduces a ...
Hosted on MSN
MeMed develops rapid infection differentiation test
MeMed has developed MeMed BV Flex, a rapid infection differentiation test that distinguishes between bacterial and viral infections. This test is set to widen the accessibility of MeMed BV to ...
MeMed has received breakthrough device designation (BDD) from the US Food and Drug Administration (FDA) for its MeMed Severity test, designed to enhance the management of patients with suspected acute ...
ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)--MeMed, a leader in host-response diagnostics, today announced the addition of three distinguished experts to its advisory board to accelerate its ...
– Milestone Achieved Through Growing Clinical Evidence Demonstrating Real-World Impact on Infection Management – – MeMed and Physicians Premier Celebrated Milestone Event in Corpus Christi, Texas – ...
HAIFA, Israel, Jan. 12, 2026 /PRNewswire/ -- MeMed, the leader in host-response diagnostics, announced it has been awarded a competitive national grant through the IIA to establish an acute-care ...
MeMed, a leader in host-response technology, today announced that Health Canada has granted Medical Device License (MDL) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results